Wednesday, January 1, 2020

WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392

SHANGHAI, Jan., 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its partner OncoImmune on the U.S. Food and...



from PR Newswire: https://ift.tt/2QC1SiW
Posted by at
Labels:

1 comment:

  1. AkshayNovember 19, 2020 at 7:44 AM

    Great Information sharing.I am very happy to read this article .. thanks for giving us go through info.Fantastic nice. I appreciate this post.Black Friday SSD Deals 2020

    ReplyDelete

Subscribe to: Post Comments (Atom)